Literature DB >> 22583848

The STEP (safety and toxicity of excipients for paediatrics) database. Part 1-A need assessment study.

Smita Salunke1, George Giacoia, Catherine Tuleu.   

Abstract

UNLABELLED: Excipients that are commonly used in adult medicines have been associated with elevated toxicological risks and safety issues in children. However, the information available on their acceptability for paediatric age groups is sparse and distributed over various sources. Hence, European (Eu) and United States (US) Paediatric Formulation Initiatives (PFIs) are collaboratively creating a STEP database. Because the development of database is a costly and time consuming venture, it is important to capture the requirements from the potential users and identify at an early stage the content and features that will serve the specific needs so that they can incorporate into the databases as it is developed. AIM: To assess the need of STEP database, to determine the database content and structure that meets the needs of the potential users.
METHOD: A global survey was conducted via EuPFI website and email invitations, targeting a representative cross section of industrial, regulatory, academic and clinical professionals, to capture the database requirements. RESULT: The survey revealed (1) the potential users of this database, (2) the excipients' toxicity and safety information needs, (3) the content and structure preferred for the database. Majority of respondents favoured the development of STEP database and reported that it would be a valuable resource. CONCLUSION AND FUTURE WORK: The survey emphasized the need for STEP database and thus leads us to development of pilot database to assess the feasibility of developing such a database.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22583848     DOI: 10.1016/j.ijpharm.2012.05.004

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  19 in total

Review 1.  Formulations for children: problems and solutions.

Authors:  Hannah K Batchelor; John F Marriott
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

2.  Biopharmaceutical optimization in neglected diseases for paediatric patients by applying the provisional paediatric biopharmaceutical classification system.

Authors:  Jose Manuel Del Moral Sanchez; Isabel Gonzalez-Alvarez; Aaron Cerda-Revert; Marta Gonzalez-Alvarez; Andres Navarro-Ruiz; Gordon L Amidon; Marival Bermejo
Journal:  Br J Clin Pharmacol       Date:  2018-07-17       Impact factor: 4.335

Review 3.  Educational paper: formulation-related issues in pediatric clinical pharmacology.

Authors:  Catherine Tuleu; Joerg Breitkreutz
Journal:  Eur J Pediatr       Date:  2012-10-31       Impact factor: 3.183

4.  Pediatric clinical pharmacology: an introduction to a series of educational papers.

Authors:  Karel Allegaert
Journal:  Eur J Pediatr       Date:  2013-01-05       Impact factor: 3.183

5.  Neonates need tailored drug formulations.

Authors:  Karel Allegaert
Journal:  World J Clin Pediatr       Date:  2013-02-08

Review 6.  Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.

Authors:  William Wei Lim Chin; Angelika Joos
Journal:  Eur J Pediatr       Date:  2016-09-19       Impact factor: 3.183

7.  Development of a Pediatric Mini-Tablet Formulation for Expedited Preclinical Studies.

Authors:  Monika Lavan; Xueqi Wang; Robyn McCain; Amber Jannasch; Bruce Cooper; Scott Hostetler; Stephen Byrn; Gregory Knipp
Journal:  AAPS PharmSciTech       Date:  2021-01-08       Impact factor: 3.246

8.  Furosemide ethanol-free oral solutions for paediatric use: formulation, HPLC method and stability study.

Authors:  Lukáš Zahálka; Sylva Klovrzová; Ludmila Matysová; Zdenka Šklubalová; Petr Solich
Journal:  Eur J Hosp Pharm       Date:  2017-08-02

9.  Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients.

Authors:  Lorrene A Buckley; Smita Salunke; Karen Thompson; Gerri Baer; Darren Fegley; Mark A Turner
Journal:  Int J Pharm       Date:  2017-07-17       Impact factor: 5.875

Review 10.  Persistent pharmacokinetic challenges to pediatric drug development.

Authors:  Daniel P Sage; Christopher Kulczar; Wyatt Roth; Wanqing Liu; Gregory T Knipp
Journal:  Front Genet       Date:  2014-08-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.